JP2005514005A

JP2005514005A - 新規のｌｎａ組成物およびその使用

新規のｌｎａ組成物およびその使用 Download PDF

Info

Publication number: JP2005514005A
Authority: JP; Japan
Prior art keywords: nucleic acid; lna; target; oligonucleotide; acid according
Prior art date: 2001-09-04
Legal status : Pending

Application number

JP2003525009A

Other languages

English (en)

Japanese (ja)

Other versions

JP2005514005A5 (https=

Inventor

ジェスパー・ウェンゲル

サカリ・カウピネン

Current Assignee

Exiqon AS

Original Assignee

Exiqon AS

Priority date

2001-09-04

Filing date

2002-09-04

Publication date

2005-05-19

2002-09-04 Application filed by Exiqon AS filed Critical Exiqon AS

2005-05-19 Publication of JP2005514005A publication Critical patent/JP2005514005A/ja

2006-01-05 Publication of JP2005514005A5 publication Critical patent/JP2005514005A5/ja

Status Pending legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title abstract description 61
150000007523 nucleic acids Chemical class 0.000 claims abstract description 357
102000039446 nucleic acids Human genes 0.000 claims abstract description 330
108020004707 nucleic acids Proteins 0.000 claims abstract description 330
108091034117 Oligonucleotide Proteins 0.000 claims abstract description 157
239000002777 nucleoside Substances 0.000 claims abstract description 53
238000009396 hybridization Methods 0.000 claims abstract description 46
150000003833 nucleoside derivatives Chemical class 0.000 claims abstract description 35
238000000034 method Methods 0.000 claims description 105
125000003729 nucleotide group Chemical group 0.000 claims description 92
239000002773 nucleotide Substances 0.000 claims description 91
-1 methoxy, propoxy, methoxy-ethoxy Chemical group 0.000 claims description 85
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 82
239000000523 sample Substances 0.000 claims description 74
108020004414 DNA Proteins 0.000 claims description 71
239000000178 monomer Substances 0.000 claims description 67
108090000623 proteins and genes Proteins 0.000 claims description 53
150000001875 compounds Chemical class 0.000 claims description 48
230000000295 complement effect Effects 0.000 claims description 47
102000004169 proteins and genes Human genes 0.000 claims description 42
102000004190 Enzymes Human genes 0.000 claims description 34
108090000790 Enzymes Proteins 0.000 claims description 34
229910052760 oxygen Inorganic materials 0.000 claims description 33
125000002723 alicyclic group Chemical group 0.000 claims description 30
239000002336 ribonucleotide Substances 0.000 claims description 29
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims description 29
238000010804 cDNA synthesis Methods 0.000 claims description 28
108020004635 Complementary DNA Proteins 0.000 claims description 27
108091028664 Ribonucleotide Proteins 0.000 claims description 27
229910052717 sulfur Inorganic materials 0.000 claims description 26
125000004429 atom Chemical group 0.000 claims description 23
238000006243 chemical reaction Methods 0.000 claims description 23
229910052739 hydrogen Inorganic materials 0.000 claims description 23
230000027455 binding Effects 0.000 claims description 22
229910052799 carbon Inorganic materials 0.000 claims description 22
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 22
239000001257 hydrogen Substances 0.000 claims description 21
230000000692 anti-sense effect Effects 0.000 claims description 20
230000014509 gene expression Effects 0.000 claims description 20
108020004999 messenger RNA Proteins 0.000 claims description 20
241000124008 Mammalia Species 0.000 claims description 19
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 18
108091034057 RNA (poly(A)) Proteins 0.000 claims description 18
239000000758 substrate Substances 0.000 claims description 18
239000001301 oxygen Substances 0.000 claims description 17
244000052769 pathogen Species 0.000 claims description 17
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 16
201000010099 disease Diseases 0.000 claims description 16
238000012986 modification Methods 0.000 claims description 16
230000004048 modification Effects 0.000 claims description 16
241000894006 Bacteria Species 0.000 claims description 15
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 15
230000001717 pathogenic effect Effects 0.000 claims description 15
KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 14
125000005842 heteroatom Chemical group 0.000 claims description 14
238000002844 melting Methods 0.000 claims description 14
230000008018 melting Effects 0.000 claims description 14
230000035772 mutation Effects 0.000 claims description 14
229910052757 nitrogen Chemical group 0.000 claims description 14
125000002652 ribonucleotide group Chemical group 0.000 claims description 11
108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 10
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 10
125000004122 cyclic group Chemical group 0.000 claims description 10
125000001725 pyrenyl group Chemical group 0.000 claims description 10
239000011593 sulfur Chemical group 0.000 claims description 10
102000012515 Protein kinase domains Human genes 0.000 claims description 9
108050002122 Protein kinase domains Proteins 0.000 claims description 9
125000005647 linker group Chemical group 0.000 claims description 9
108090000765 processed proteins & peptides Proteins 0.000 claims description 9
238000010839 reverse transcription Methods 0.000 claims description 9
230000000087 stabilizing effect Effects 0.000 claims description 9
DGYMBCUDYNBMHT-UHFFFAOYSA-N 4-pyren-1-ylbutane-1,2,3-triol Chemical class C1=C2C(CC(O)C(O)CO)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 DGYMBCUDYNBMHT-UHFFFAOYSA-N 0.000 claims description 8
241000203069 Archaea Species 0.000 claims description 8
HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 8
102000053602 DNA Human genes 0.000 claims description 8
WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims description 8
238000013461 design Methods 0.000 claims description 8
BNBQQYFXBLBYJK-UHFFFAOYSA-N 2-pyridin-2-yl-1,3-oxazole Chemical class C1=COC(C=2N=CC=CC=2)=N1 BNBQQYFXBLBYJK-UHFFFAOYSA-N 0.000 claims description 7
102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 7
108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 7
108020005187 Oligonucleotide Probes Proteins 0.000 claims description 7
102000001253 Protein Kinase Human genes 0.000 claims description 7
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 7
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 7
125000002619 bicyclic group Chemical group 0.000 claims description 7
238000011534 incubation Methods 0.000 claims description 7
208000015181 infectious disease Diseases 0.000 claims description 7
239000002751 oligonucleotide probe Substances 0.000 claims description 7
150000003852 triazoles Chemical class 0.000 claims description 7
239000012472 biological sample Substances 0.000 claims description 6
208000035475 disorder Diseases 0.000 claims description 6
239000000284 extract Substances 0.000 claims description 6
150000004676 glycans Chemical class 0.000 claims description 6
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical class O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims description 6
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 6
238000004519 manufacturing process Methods 0.000 claims description 6
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 6
102000040430 polynucleotide Human genes 0.000 claims description 6
108091033319 polynucleotide Proteins 0.000 claims description 6
239000002157 polynucleotide Substances 0.000 claims description 6
229920001282 polysaccharide Polymers 0.000 claims description 6
239000005017 polysaccharide Substances 0.000 claims description 6
238000002360 preparation method Methods 0.000 claims description 6
108060006633 protein kinase Proteins 0.000 claims description 6
229910052711 selenium Inorganic materials 0.000 claims description 6
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
108091006112 ATPases Proteins 0.000 claims description 5
102000057290 Adenosine Triphosphatases Human genes 0.000 claims description 5
102000004580 Aspartic Acid Proteases Human genes 0.000 claims description 5
108010017640 Aspartic Acid Proteases Proteins 0.000 claims description 5
102000004163 DNA-directed RNA polymerases Human genes 0.000 claims description 5
108090000626 DNA-directed RNA polymerases Proteins 0.000 claims description 5
101100226058 Dictyostelium discoideum erkB gene Proteins 0.000 claims description 5
241000206602 Eukaryota Species 0.000 claims description 5
241000711549 Hepacivirus C Species 0.000 claims description 5
108091000080 Phosphotransferase Proteins 0.000 claims description 5
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
125000002947 alkylene group Chemical group 0.000 claims description 5
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 5
125000004430 oxygen atom Chemical group O* 0.000 claims description 5
102000020233 phosphotransferase Human genes 0.000 claims description 5
108091093037 Peptide nucleic acid Proteins 0.000 claims description 4
101710132593 Protein E2 Proteins 0.000 claims description 4
108020004682 Single-Stranded DNA Proteins 0.000 claims description 4
125000004450 alkenylene group Chemical group 0.000 claims description 4
238000005516 engineering process Methods 0.000 claims description 4
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
230000002401 inhibitory effect Effects 0.000 claims description 4
239000008194 pharmaceutical composition Substances 0.000 claims description 4
150000003233 pyrroles Chemical class 0.000 claims description 4
230000001177 retroviral effect Effects 0.000 claims description 4
125000006413 ring segment Chemical group 0.000 claims description 4
OZFPSOBLQZPIAV-UHFFFAOYSA-N 5-nitro-1h-indole Chemical class [O-][N+](=O)C1=CC=C2NC=CC2=C1 OZFPSOBLQZPIAV-UHFFFAOYSA-N 0.000 claims description 3
108091093088 Amplicon Proteins 0.000 claims description 3
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Chemical class OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 claims description 3
125000004103 aminoalkyl group Chemical group 0.000 claims description 3
125000001153 fluoro group Chemical group F* 0.000 claims description 3
108091008146 restriction endonucleases Proteins 0.000 claims description 3
108700028369 Alleles Proteins 0.000 claims description 2
230000004568 DNA-binding Effects 0.000 claims description 2
ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 2
238000006555 catalytic reaction Methods 0.000 claims description 2
230000008859 change Effects 0.000 claims description 2
125000001309 chloro group Chemical group Cl* 0.000 claims description 2
239000005547 deoxyribonucleotide Substances 0.000 claims description 2
125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 claims description 2
102100034343 Integrase Human genes 0.000 claims 2
125000002637 deoxyribonucleotide group Chemical group 0.000 claims 1
230000015572 biosynthetic process Effects 0.000 abstract description 31
238000003786 synthesis reaction Methods 0.000 abstract description 31
238000012163 sequencing technique Methods 0.000 abstract description 12
238000006467 substitution reaction Methods 0.000 abstract description 6
239000000074 antisense oligonucleotide Substances 0.000 abstract description 2
238000012230 antisense oligonucleotides Methods 0.000 abstract description 2
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 171
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 69
239000013615 primer Substances 0.000 description 58
BBEAQIROQSPTKN-UHFFFAOYSA-N antipyrene Natural products C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 40
238000004440 column chromatography Methods 0.000 description 40
235000018102 proteins Nutrition 0.000 description 38
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 32
229940088598 enzyme Drugs 0.000 description 25
125000004432 carbon atom Chemical group C* 0.000 description 24
210000004027 cell Anatomy 0.000 description 24
239000002299 complementary DNA Substances 0.000 description 24
239000000243 solution Substances 0.000 description 24
125000001424 substituent group Chemical group 0.000 description 23
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 22
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 22
GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 22
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
150000001299 aldehydes Chemical class 0.000 description 20
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 20
238000010265 fast atom bombardment Methods 0.000 description 19
150000008300 phosphoramidites Chemical class 0.000 description 19
206010028980 Neoplasm Diseases 0.000 description 18
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
125000003118 aryl group Chemical group 0.000 description 18
230000002829 reductive effect Effects 0.000 description 18
239000011343 solid material Substances 0.000 description 18
239000000872 buffer Substances 0.000 description 16
238000001514 detection method Methods 0.000 description 16
230000003993 interaction Effects 0.000 description 16
239000003446 ligand Substances 0.000 description 16
239000011734 sodium Substances 0.000 description 16
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 15
125000003835 nucleoside group Chemical group 0.000 description 15
125000006853 reporter group Chemical group 0.000 description 15
238000010626 work up procedure Methods 0.000 description 15
229930024421 Adenine Natural products 0.000 description 14
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical group O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 14
125000001072 heteroaryl group Chemical group 0.000 description 14
235000000346 sugar Nutrition 0.000 description 14
229960000643 adenine Drugs 0.000 description 13
102000005744 Glycoside Hydrolases Human genes 0.000 description 12
108010031186 Glycoside Hydrolases Proteins 0.000 description 12
238000004458 analytical method Methods 0.000 description 12
239000002987 primer (paints) Substances 0.000 description 12
125000006850 spacer group Chemical group 0.000 description 12
229940113082 thymine Drugs 0.000 description 12
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 11
238000003776 cleavage reaction Methods 0.000 description 11
239000012043 crude product Substances 0.000 description 11
229940104302 cytosine Drugs 0.000 description 11
239000012074 organic phase Substances 0.000 description 11
238000000746 purification Methods 0.000 description 11
238000011160 research Methods 0.000 description 11
229940035893 uracil Drugs 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 10
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 10
239000002253 acid Substances 0.000 description 10
201000011510 cancer Diseases 0.000 description 10
230000008878 coupling Effects 0.000 description 10
238000010168 coupling process Methods 0.000 description 10
238000005859 coupling reaction Methods 0.000 description 10
229920006395 saturated elastomer Polymers 0.000 description 10
230000007017 scission Effects 0.000 description 10
239000007787 solid Substances 0.000 description 10
101100532034 Drosophila melanogaster RTase gene Proteins 0.000 description 9
102100031780 Endonuclease Human genes 0.000 description 9
241001465754 Metazoa Species 0.000 description 9
108020004711 Nucleic Acid Probes Proteins 0.000 description 9
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
239000012267 brine Substances 0.000 description 9
125000002837 carbocyclic group Chemical group 0.000 description 9
239000012230 colorless oil Substances 0.000 description 9
125000002887 hydroxy group Chemical group [H]O* 0.000 description 9
239000002853 nucleic acid probe Substances 0.000 description 9
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 9
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 8
108091028043 Nucleic acid sequence Proteins 0.000 description 8
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 8
150000002431 hydrogen Chemical class 0.000 description 8
238000010348 incorporation Methods 0.000 description 8
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 8
239000011541 reaction mixture Substances 0.000 description 8
238000000926 separation method Methods 0.000 description 8
VLSDXINSOMDCBK-BQYQJAHWSA-N (E)-1,1'-azobis(N,N-dimethylformamide) Chemical compound CN(C)C(=O)\N=N\C(=O)N(C)C VLSDXINSOMDCBK-BQYQJAHWSA-N 0.000 description 7
239000012625 DNA intercalator Substances 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Chemical group OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 7
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Chemical group OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 7
239000003814 drug Substances 0.000 description 7
229910052736 halogen Inorganic materials 0.000 description 7
150000002367 halogens Chemical class 0.000 description 7
238000007363 ring formation reaction Methods 0.000 description 7
239000003155 DNA primer Substances 0.000 description 6
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 6
240000004808 Saccharomyces cerevisiae Species 0.000 description 6
125000003545 alkoxy group Chemical group 0.000 description 6
230000003321 amplification Effects 0.000 description 6
238000003556 assay Methods 0.000 description 6
230000000694 effects Effects 0.000 description 6
150000002243 furanoses Chemical group 0.000 description 6
125000000623 heterocyclic group Chemical group 0.000 description 6
238000003199 nucleic acid amplification method Methods 0.000 description 6
239000003921 oil Substances 0.000 description 6
102000004196 processed proteins & peptides Human genes 0.000 description 6
150000003254 radicals Chemical group 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
125000006619 (C1-C6) dialkylamino group Chemical group 0.000 description 5
JBWYRBLDOOOJEU-UHFFFAOYSA-N 1-[chloro-(4-methoxyphenyl)-phenylmethyl]-4-methoxybenzene Chemical compound C1=CC(OC)=CC=C1C(Cl)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 JBWYRBLDOOOJEU-UHFFFAOYSA-N 0.000 description 5
QCMHGCDOZLWPOT-FMNCTDSISA-N COC1=C(CC[C@@H]2CCC3=C(C2)C=CC(=C3)[C@H]2CC[C@](N)(CO)C2)C=CC=C1 Chemical compound COC1=C(CC[C@@H]2CCC3=C(C2)C=CC(=C3)[C@H]2CC[C@](N)(CO)C2)C=CC=C1 QCMHGCDOZLWPOT-FMNCTDSISA-N 0.000 description 5
238000001712 DNA sequencing Methods 0.000 description 5
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
241000233866 Fungi Species 0.000 description 5
238000005481 NMR spectroscopy Methods 0.000 description 5
102000006382 Ribonucleases Human genes 0.000 description 5
108010083644 Ribonucleases Proteins 0.000 description 5
241000700605 Viruses Species 0.000 description 5
125000000217 alkyl group Chemical group 0.000 description 5
150000001413 amino acids Chemical class 0.000 description 5
125000005161 aryl oxy carbonyl group Chemical group 0.000 description 5
125000004104 aryloxy group Chemical group 0.000 description 5
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
238000004587 chromatography analysis Methods 0.000 description 5
238000004925 denaturation Methods 0.000 description 5
230000036425 denaturation Effects 0.000 description 5
235000019439 ethyl acetate Nutrition 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
239000012634 fragment Substances 0.000 description 5
230000006870 function Effects 0.000 description 5
230000002068 genetic effect Effects 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
238000003757 reverse transcription PCR Methods 0.000 description 5
238000012216 screening Methods 0.000 description 5
230000004083 survival effect Effects 0.000 description 5
230000001225 therapeutic effect Effects 0.000 description 5
125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 4
CODBZFJPKJDNDT-UHFFFAOYSA-N 2-[[5-[3-(dimethylamino)propyl]-2-methylpyridin-3-yl]amino]-9-(trifluoromethyl)-5,7-dihydropyrimido[5,4-d][1]benzazepine-6-thione Chemical compound CN(C)CCCC1=CN=C(C)C(NC=2N=C3C4=CC=C(C=C4NC(=S)CC3=CN=2)C(F)(F)F)=C1 CODBZFJPKJDNDT-UHFFFAOYSA-N 0.000 description 4
125000005947 C1-C6 alkylsulfonyloxy group Chemical group 0.000 description 4
108010042407 Endonucleases Proteins 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 4
229930010555 Inosine Natural products 0.000 description 4
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
ZNSPHKJFQDEABI-NZQKXSOJSA-N Nc1nc(O[C@H](c2ccc(Cl)cc2-c2ccccc2)C(F)(F)F)cc(n1)N1CCC2(CN[C@@H](C2)C(O)=O)CC1 Chemical compound Nc1nc(O[C@H](c2ccc(Cl)cc2-c2ccccc2)C(F)(F)F)cc(n1)N1CCC2(CN[C@@H](C2)C(O)=O)CC1 ZNSPHKJFQDEABI-NZQKXSOJSA-N 0.000 description 4
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
108020004566 Transfer RNA Proteins 0.000 description 4
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 4
125000002252 acyl group Chemical group 0.000 description 4
229960002685 biotin Drugs 0.000 description 4
235000020958 biotin Nutrition 0.000 description 4
239000011616 biotin Substances 0.000 description 4
239000004202 carbamide Substances 0.000 description 4
235000013877 carbamide Nutrition 0.000 description 4
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
150000001735 carboxylic acids Chemical class 0.000 description 4
229940125876 compound 15a Drugs 0.000 description 4
238000004132 cross linking Methods 0.000 description 4
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 4
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 4
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 4
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 4
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 4
229940079593 drug Drugs 0.000 description 4
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 4
125000000524 functional group Chemical class 0.000 description 4
125000003843 furanosyl group Chemical group 0.000 description 4
229960003786 inosine Drugs 0.000 description 4
238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 4
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 4
DYMRYCZRMAHYKE-UHFFFAOYSA-N n-diazonitramide Chemical compound [O-][N+](=O)N=[N+]=[N-] DYMRYCZRMAHYKE-UHFFFAOYSA-N 0.000 description 4
239000000047 product Substances 0.000 description 4
150000003220 pyrenes Chemical class 0.000 description 4
230000009467 reduction Effects 0.000 description 4
239000011347 resin Substances 0.000 description 4
229920005989 resin Polymers 0.000 description 4
239000003161 ribonuclease inhibitor Substances 0.000 description 4
150000003839 salts Chemical class 0.000 description 4
241000894007 species Species 0.000 description 4
239000000126 substance Substances 0.000 description 4
CYFLXLSBHQBMFT-UHFFFAOYSA-N sulfamoxole Chemical group O1C(C)=C(C)N=C1NS(=O)(=O)C1=CC=C(N)C=C1 CYFLXLSBHQBMFT-UHFFFAOYSA-N 0.000 description 4
125000004434 sulfur atom Chemical group 0.000 description 4
239000000725 suspension Substances 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
NUJWKQSEJDYCDB-GNRVTEMESA-N (3s)-1-[(1s,2r,4r)-4-[methyl(propan-2-yl)amino]-2-propylcyclohexyl]-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-2-one Chemical compound CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 NUJWKQSEJDYCDB-GNRVTEMESA-N 0.000 description 3
FJZNNKJZHQFMCK-LRDDRELGSA-N 1-[(3S,4R)-4-(2,6-difluoro-4-methoxyphenyl)-2-oxopyrrolidin-3-yl]-3-phenylurea Chemical compound C1(=CC(=CC(=C1[C@H]1[C@@H](C(=O)NC1)NC(=O)NC1=CC=CC=C1)F)OC)F FJZNNKJZHQFMCK-LRDDRELGSA-N 0.000 description 3
RYWCQJDEHXJHRI-XJMXIVSISA-N 2-[3-[5-[6-[3-[3-(carboxymethyl)phenyl]-4-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]hexyl]-2-[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]phenyl]acetic acid Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC(C(=C1)C=2C=C(CC(O)=O)C=CC=2)=CC=C1CCCCCCC(C=C1C=2C=C(CC(O)=O)C=CC=2)=CC=C1O[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 RYWCQJDEHXJHRI-XJMXIVSISA-N 0.000 description 3
TXEBWPPWSVMYOA-UHFFFAOYSA-N 4-[3-[(1-amino-2-chloroethyl)amino]propyl]-1-[[3-(2-chlorophenyl)phenyl]methyl]-5-hydroxyimidazolidin-2-one Chemical compound NC(CCl)NCCCC1NC(=O)N(Cc2cccc(c2)-c2ccccc2Cl)C1O TXEBWPPWSVMYOA-UHFFFAOYSA-N 0.000 description 3
WCDLCPLAAKUJNY-UHFFFAOYSA-N 4-[4-[3-(1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-6-yl]phenyl]morpholine Chemical compound C1COCCN1C1=CC=C(C2=CN3N=CC(=C3N=C2)C2=CNN=C2)C=C1 WCDLCPLAAKUJNY-UHFFFAOYSA-N 0.000 description 3
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
VKKXEIQIGGPMHT-UHFFFAOYSA-N 7h-purine-2,8-diamine Chemical compound NC1=NC=C2NC(N)=NC2=N1 VKKXEIQIGGPMHT-UHFFFAOYSA-N 0.000 description 3
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
206010009944 Colon cancer Diseases 0.000 description 3
101710118273 DNA repair protein RAD10 Proteins 0.000 description 3
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
241000588724 Escherichia coli Species 0.000 description 3
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
101710163270 Nuclease Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
241000710886 West Nile virus Species 0.000 description 3
125000004644 alkyl sulfinyl group Chemical group 0.000 description 3
125000004390 alkyl sulfonyl group Chemical group 0.000 description 3
125000004414 alkyl thio group Chemical group 0.000 description 3
235000001014 amino acid Nutrition 0.000 description 3
229940024606 amino acid Drugs 0.000 description 3
238000000137 annealing Methods 0.000 description 3
150000004056 anthraquinones Chemical class 0.000 description 3
230000006907 apoptotic process Effects 0.000 description 3
238000013459 approach Methods 0.000 description 3
125000003710 aryl alkyl group Chemical group 0.000 description 3
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
238000010367 cloning Methods 0.000 description 3
229940127206 compound 14d Drugs 0.000 description 3
238000005520 cutting process Methods 0.000 description 3
238000010511 deprotection reaction Methods 0.000 description 3
238000002523 gelfiltration Methods 0.000 description 3
125000005843 halogen group Chemical group 0.000 description 3
150000002429 hydrazines Chemical class 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
238000001727 in vivo Methods 0.000 description 3
230000009545 invasion Effects 0.000 description 3
229910052740 iodine Inorganic materials 0.000 description 3
239000011630 iodine Substances 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
229910052749 magnesium Inorganic materials 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
239000002480 mineral oil Substances 0.000 description 3
235000010446 mineral oil Nutrition 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
125000004433 nitrogen atom Chemical group N* 0.000 description 3
229920001542 oligosaccharide Polymers 0.000 description 3
150000002482 oligosaccharides Polymers 0.000 description 3
229910052698 phosphorus Inorganic materials 0.000 description 3
125000003386 piperidinyl group Chemical group 0.000 description 3
238000003752 polymerase chain reaction Methods 0.000 description 3
230000002265 prevention Effects 0.000 description 3
125000006239 protecting group Chemical group 0.000 description 3
125000005581 pyrene group Chemical group 0.000 description 3
125000000719 pyrrolidinyl group Chemical group 0.000 description 3
150000004053 quinones Chemical class 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
TZSZZENYCISATO-WIOPSUGQSA-N rodatristat Chemical compound CCOC(=O)[C@@H]1CC2(CN1)CCN(CC2)c1cc(O[C@H](c2ccc(Cl)cc2-c2ccccc2)C(F)(F)F)nc(N)n1 TZSZZENYCISATO-WIOPSUGQSA-N 0.000 description 3
229910000104 sodium hydride Inorganic materials 0.000 description 3
239000001488 sodium phosphate Substances 0.000 description 3
229910000162 sodium phosphate Inorganic materials 0.000 description 3
238000012289 standard assay Methods 0.000 description 3
238000010561 standard procedure Methods 0.000 description 3
239000003826 tablet Substances 0.000 description 3
FRACPXUHUTXLCX-BELIEFIBSA-N tert-butyl N-{1-[(1S)-1-{[(1R,2S)-1-(benzylcarbamoyl)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]carbamoyl}-2-cyclopropylethyl]-2-oxopyridin-3-yl}carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=CN(C1=O)[C@@H](CC2CC2)C(=O)N[C@@H](C[C@@H]3CCNC3=O)[C@H](C(=O)NCC4=CC=CC=C4)O FRACPXUHUTXLCX-BELIEFIBSA-N 0.000 description 3
125000001412 tetrahydropyranyl group Chemical group 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
125000003396 thiol group Chemical group [H]S* 0.000 description 3
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 3
BFDBKMOZYNOTPK-UHFFFAOYSA-N vonoprazan Chemical compound C=1C=CN=CC=1S(=O)(=O)N1C=C(CNC)C=C1C1=CC=CC=C1F BFDBKMOZYNOTPK-UHFFFAOYSA-N 0.000 description 3
238000005406 washing Methods 0.000 description 3
125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 description 2
125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 description 2
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
YKYWUHHZZRBGMG-JWTNVVGKSA-N 1-methyl-2-[[(1r,5s)-6-[[5-(trifluoromethyl)pyridin-2-yl]methoxymethyl]-3-azabicyclo[3.1.0]hexan-3-yl]methyl]benzimidazole Chemical compound C1([C@@H]2CN(C[C@@H]21)CC=1N(C2=CC=CC=C2N=1)C)COCC1=CC=C(C(F)(F)F)C=N1 YKYWUHHZZRBGMG-JWTNVVGKSA-N 0.000 description 2
KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 2
XQCZBXHVTFVIFE-UHFFFAOYSA-N 2-amino-4-hydroxypyrimidine Chemical group NC1=NC=CC(O)=N1 XQCZBXHVTFVIFE-UHFFFAOYSA-N 0.000 description 2
ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical group OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 2
125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 2
DCXJOVUZENRYSH-UHFFFAOYSA-N 4,4-dimethyloxazolidine-N-oxyl Chemical compound CC1(C)COCN1[O] DCXJOVUZENRYSH-UHFFFAOYSA-N 0.000 description 2
KUZSBKJSGSKPJH-VXGBXAGGSA-N 5-[(9R)-6-[(3R)-3-methylmorpholin-4-yl]-11-oxa-1,3,5-triazatricyclo[7.4.0.02,7]trideca-2,4,6-trien-4-yl]pyrazin-2-amine Chemical compound C[C@@H]1COCCN1c1nc(nc2N3CCOC[C@H]3Cc12)-c1cnc(N)cn1 KUZSBKJSGSKPJH-VXGBXAGGSA-N 0.000 description 2
LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 2
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical group CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 2
OPKFWRVRCVCMJH-UHFFFAOYSA-N 6-methylnaphthalene-1,4-dione Chemical compound O=C1C=CC(=O)C2=CC(C)=CC=C21 OPKFWRVRCVCMJH-UHFFFAOYSA-N 0.000 description 2
MITGKKFYIJJQGL-UHFFFAOYSA-N 9-(4-chlorobenzoyl)-6-methylsulfonyl-2,3-dihydro-1H-carbazol-4-one Chemical compound ClC1=CC=C(C(=O)N2C3=CC=C(C=C3C=3C(CCCC2=3)=O)S(=O)(=O)C)C=C1 MITGKKFYIJJQGL-UHFFFAOYSA-N 0.000 description 2
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
208000035143 Bacterial infection Diseases 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
125000000882 C2-C6 alkenyl group Chemical group 0.000 description 2
125000003320 C2-C6 alkenyloxy group Chemical group 0.000 description 2
GFMYEVPBEJFZHH-UHFFFAOYSA-N CP(O)(O)O Chemical compound CP(O)(O)O GFMYEVPBEJFZHH-UHFFFAOYSA-N 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
241000709687 Coxsackievirus Species 0.000 description 2
230000033616 DNA repair Effects 0.000 description 2
SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
102000004533 Endonucleases Human genes 0.000 description 2
241001522957 Enterococcus casseliflavus Species 0.000 description 2
229910052693 Europium Inorganic materials 0.000 description 2
241000282412 Homo Species 0.000 description 2
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
241000588655 Moraxella catarrhalis Species 0.000 description 2
UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
108091036407 Polyadenylation Proteins 0.000 description 2
239000004952 Polyamide Substances 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
108010039918 Polylysine Proteins 0.000 description 2
229920000388 Polyphosphate Polymers 0.000 description 2
241000288906 Primates Species 0.000 description 2
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
241000193996 Streptococcus pyogenes Species 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical compound OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 2
108091036066 Three prime untranslated region Proteins 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
241000251539 Vertebrata <Metazoa> Species 0.000 description 2
208000036142 Viral infection Diseases 0.000 description 2
KSQVGVMZECCPAT-AEFFLSMTSA-N [(1R)-4-phenyl-1-[[(2R)-2-(pyrazine-2-carbonylamino)pentanoyl]amino]butyl]boronic acid Chemical compound B([C@H](CCCC1=CC=CC=C1)NC(=O)[C@@H](CCC)NC(=O)C2=NC=CN=C2)(O)O KSQVGVMZECCPAT-AEFFLSMTSA-N 0.000 description 2
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
239000013543 active substance Substances 0.000 description 2
125000004442 acylamino group Chemical group 0.000 description 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
150000001336 alkenes Chemical class 0.000 description 2
150000001345 alkine derivatives Chemical class 0.000 description 2
125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
150000001350 alkyl halides Chemical class 0.000 description 2
229910000147 aluminium phosphate Inorganic materials 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
229940088710 antibiotic agent Drugs 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
229940041181 antineoplastic drug Drugs 0.000 description 2
125000003435 aroyl group Chemical group 0.000 description 2
238000003491 array Methods 0.000 description 2
125000004659 aryl alkyl thio group Chemical group 0.000 description 2
125000005129 aryl carbonyl group Chemical group 0.000 description 2
125000005135 aryl sulfinyl group Chemical group 0.000 description 2
125000004391 aryl sulfonyl group Chemical group 0.000 description 2
125000005110 aryl thio group Chemical group 0.000 description 2
208000022362 bacterial infectious disease Diseases 0.000 description 2
244000052616 bacterial pathogen Species 0.000 description 2
230000037429 base substitution Effects 0.000 description 2
239000011324 bead Substances 0.000 description 2
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 2
238000004166 bioassay Methods 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000037396 body weight Effects 0.000 description 2
125000001246 bromo group Chemical group Br* 0.000 description 2
239000006227 byproduct Substances 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
238000001818 capillary gel electrophoresis Methods 0.000 description 2
239000002775 capsule Substances 0.000 description 2
150000001721 carbon Chemical class 0.000 description 2
150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
238000007385 chemical modification Methods 0.000 description 2
229940126214 compound 3 Drugs 0.000 description 2
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
230000001627 detrimental effect Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000029087 digestion Effects 0.000 description 2
QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 2
SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 2
230000008034 disappearance Effects 0.000 description 2
150000002019 disulfides Chemical class 0.000 description 2
NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical compound OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 2
238000009510 drug design Methods 0.000 description 2
238000010828 elution Methods 0.000 description 2
150000002118 epoxides Chemical class 0.000 description 2
150000002148 esters Chemical class 0.000 description 2
238000012869 ethanol precipitation Methods 0.000 description 2
OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 2
238000000605 extraction Methods 0.000 description 2
238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
239000007850 fluorescent dye Substances 0.000 description 2
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
238000012268 genome sequencing Methods 0.000 description 2
229930182470 glycoside Natural products 0.000 description 2
150000002338 glycosides Chemical class 0.000 description 2
ZUUBRGCTXRXCLV-UHFFFAOYSA-N gtpl6357 Chemical compound C1=CC(OC)=CC=C1N1C(=O)C(SC=2C3=C(NC4CC4)C=CN=2)=C3C=C1 ZUUBRGCTXRXCLV-UHFFFAOYSA-N 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
125000005223 heteroarylcarbonyl group Chemical group 0.000 description 2
125000005150 heteroarylsulfinyl group Chemical group 0.000 description 2
125000005143 heteroarylsulfonyl group Chemical group 0.000 description 2
125000005368 heteroarylthio group Chemical group 0.000 description 2
BRWIZMBXBAOCCF-UHFFFAOYSA-N hydrazinecarbothioamide Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 description 2
229930195733 hydrocarbon Natural products 0.000 description 2
150000002430 hydrocarbons Chemical class 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
125000002768 hydroxyalkyl group Chemical group 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
238000009830 intercalation Methods 0.000 description 2
230000002687 intercalation Effects 0.000 description 2
238000007918 intramuscular administration Methods 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
238000001990 intravenous administration Methods 0.000 description 2
238000011835 investigation Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
DRAVOWXCEBXPTN-UHFFFAOYSA-N isoguanine Chemical compound NC1=NC(=O)NC2=C1NC=N2 DRAVOWXCEBXPTN-UHFFFAOYSA-N 0.000 description 2
150000002576 ketones Chemical class 0.000 description 2
238000002372 labelling Methods 0.000 description 2
239000007788 liquid Substances 0.000 description 2
125000001921 locked nucleotide group Chemical group 0.000 description 2
125000005439 maleimidyl group Chemical class C1(C=CC(N1*)=O)=O 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
239000003550 marker Substances 0.000 description 2
238000005259 measurement Methods 0.000 description 2
238000003328 mesylation reaction Methods 0.000 description 2
QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
238000002493 microarray Methods 0.000 description 2
125000002950 monocyclic group Chemical group 0.000 description 2
238000002887 multiple sequence alignment Methods 0.000 description 2
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
125000001624 naphthyl group Chemical group 0.000 description 2
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
229920002842 oligophosphate Polymers 0.000 description 2
125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
125000003551 oxepanyl group Chemical group 0.000 description 2
230000001590 oxidative effect Effects 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
239000002245 particle Substances 0.000 description 2
YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 2
229920002647 polyamide Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
108010094020 polyglycine Proteins 0.000 description 2
229920000656 polylysine Polymers 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
239000001205 polyphosphate Substances 0.000 description 2
235000011176 polyphosphates Nutrition 0.000 description 2
239000000843 powder Substances 0.000 description 2
150000003138 primary alcohols Chemical class 0.000 description 2
150000003141 primary amines Chemical class 0.000 description 2
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
238000011002 quantification Methods 0.000 description 2
239000000376 reactant Substances 0.000 description 2
108020003175 receptors Proteins 0.000 description 2
102000005962 receptors Human genes 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
239000002342 ribonucleoside Substances 0.000 description 2
229910052707 ruthenium Inorganic materials 0.000 description 2
150000003333 secondary alcohols Chemical class 0.000 description 2
150000003335 secondary amines Chemical class 0.000 description 2
DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 description 2
DVWOYOSIEJRHKW-UIRZNSHLSA-M sodium (2S)-2-[[(2S)-2-[[(4,4-difluorocyclohexyl)-phenylmethoxy]carbonylamino]-4-methylpentanoyl]amino]-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonate Chemical compound FC1(CCC(CC1)C(OC(=O)N[C@H](C(=O)N[C@H](C(S(=O)(=O)[O-])O)C[C@H]1C(NCC1)=O)CC(C)C)C1=CC=CC=C1)F.[Na+] DVWOYOSIEJRHKW-UIRZNSHLSA-M 0.000 description 2
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000009987 spinning Methods 0.000 description 2
230000000707 stereoselective effect Effects 0.000 description 2
150000003431 steroids Chemical group 0.000 description 2
239000012258 stirred mixture Substances 0.000 description 2
238000007920 subcutaneous administration Methods 0.000 description 2
125000003107 substituted aryl group Chemical group 0.000 description 2
150000003459 sulfonic acid esters Chemical class 0.000 description 2
208000024891 symptom Diseases 0.000 description 2
150000003509 tertiary alcohols Chemical class 0.000 description 2
150000003512 tertiary amines Chemical class 0.000 description 2
238000012360 testing method Methods 0.000 description 2
125000003507 tetrahydrothiofenyl group Chemical group 0.000 description 2
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
125000005458 thianyl group Chemical group 0.000 description 2
125000001583 thiepanyl group Chemical group 0.000 description 2
238000004809 thin layer chromatography Methods 0.000 description 2
150000003573 thiols Chemical class 0.000 description 2
230000009385 viral infection Effects 0.000 description 2
238000012800 visualization Methods 0.000 description 2
125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 description 2
HSSJVMDOEZTAJG-AYXCPNKJSA-N (1r,4r,6s,7s)-4-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-6-(2,4,5-trimethylphenyl)-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C([C@]12CO[C@@]([C@@H](O2)C=2C(=CC(C)=C(C)C=2)C)([C@@H]1O)[H])OC(C=1C=CC(OC)=CC=1)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 HSSJVMDOEZTAJG-AYXCPNKJSA-N 0.000 description 1
AWEZWJUAARORBH-ZWDYZTTJSA-N (1r,4r,6s,7s)-4-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-6-(4-fluoro-3-methylphenyl)-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C([C@]12CO[C@@]([C@@H](O2)C=2C=C(C)C(F)=CC=2)([C@@H]1O)[H])OC(C=1C=CC(OC)=CC=1)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 AWEZWJUAARORBH-ZWDYZTTJSA-N 0.000 description 1
DAMNQPVDJJPALE-RTNMLALUSA-N (1r,4r,6s,7s)-4-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-6-phenyl-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C([C@]12CO[C@@]([C@@H](O2)C=2C=CC=CC=2)([C@@H]1O)[H])OC(C=1C=CC(OC)=CC=1)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 DAMNQPVDJJPALE-RTNMLALUSA-N 0.000 description 1
SAEPAWQXWSBWCD-QSJDGAHRSA-N (1r,4r,6s,7s)-4-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-6-pyren-1-yl-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C([C@]12CO[C@@]([C@@H](O2)C=2C3=CC=C4C=CC=C5C=CC(C3=C54)=CC=2)([C@@H]1O)[H])OC(C=1C=CC(OC)=CC=1)(C=1C=CC(OC)=CC=1)C1=CC=CC=C1 SAEPAWQXWSBWCD-QSJDGAHRSA-N 0.000 description 1
LFRKVTBQYGLYNH-AJNGGQMLSA-N (1r,4s,6s,7s)-4-(hydroxymethyl)-6-(2,4,5-trimethylphenyl)-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C1([C@@H]2O[C@]3(CO[C@@]2([C@@H]3O)[H])CO)=CC(C)=C(C)C=C1C LFRKVTBQYGLYNH-AJNGGQMLSA-N 0.000 description 1
OLMLLECODPDFFK-VGWMRTNUSA-N (1r,4s,6s,7s)-4-(hydroxymethyl)-6-naphthalen-1-yl-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C1=CC=C2C([C@@H]3O[C@]4(CO[C@@]3([C@@H]4O)[H])CO)=CC=CC2=C1 OLMLLECODPDFFK-VGWMRTNUSA-N 0.000 description 1
GOFJPLMKIUWGKX-BJDJZHNGSA-N (1r,4s,6s,7s)-4-(hydroxymethyl)-6-phenyl-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C1([C@@H]2O[C@]3(CO[C@@]2([C@@H]3O)[H])CO)=CC=CC=C1 GOFJPLMKIUWGKX-BJDJZHNGSA-N 0.000 description 1
MORCTBZRDPBFCX-CMOCDZPBSA-N (1r,4s,6s,7s)-4-(hydroxymethyl)-6-pyren-1-yl-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C1=C2C([C@@H]3O[C@]4(CO[C@@]3([C@@H]4O)[H])CO)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 MORCTBZRDPBFCX-CMOCDZPBSA-N 0.000 description 1
ZFHMUGXDVDRKLN-CYDGBPFRSA-N (1r,4s,6s,7s)-6-(4-fluoro-3-methylphenyl)-4-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-7-ol Chemical compound C1([C@@H]2O[C@]3(CO[C@@]2([C@@H]3O)[H])CO)=CC=C(F)C(C)=C1 ZFHMUGXDVDRKLN-CYDGBPFRSA-N 0.000 description 1
FPIIQZFHRYMTGV-CRNKYVSFSA-N (1r,4s,6s,7s)-6-(4-fluoro-3-methylphenyl)-7-[(4-methoxyphenyl)methoxy]-4-[(4-methoxyphenyl)methoxymethyl]-2,5-dioxabicyclo[2.2.1]heptane Chemical compound C([C@]12CO[C@]([C@@H](O2)C=2C=C(C)C(F)=CC=2)([C@@H]1OCC=1C=CC(OC)=CC=1)[H])OCC1=CC=C(OC)C=C1 FPIIQZFHRYMTGV-CRNKYVSFSA-N 0.000 description 1
UAPKLDWRIOXISQ-JVVMDBNWSA-N (1r,4s,6s,7s)-7-[(4-methoxyphenyl)methoxy]-4-[(4-methoxyphenyl)methoxymethyl]-6-(2,4,5-trimethylphenyl)-2,5-dioxabicyclo[2.2.1]heptane Chemical compound C([C@]12CO[C@]([C@@H](O2)C=2C(=CC(C)=C(C)C=2)C)([C@@H]1OCC=1C=CC(OC)=CC=1)[H])OCC1=CC=C(OC)C=C1 UAPKLDWRIOXISQ-JVVMDBNWSA-N 0.000 description 1
IPFAQMNAEFGGLO-RACKDBBVSA-N (1r,4s,6s,7s)-7-[(4-methoxyphenyl)methoxy]-4-[(4-methoxyphenyl)methoxymethyl]-6-naphthalen-1-yl-2,5-dioxabicyclo[2.2.1]heptane Chemical compound C([C@]12CO[C@]([C@@H](O2)C=2C3=CC=CC=C3C=CC=2)([C@@H]1OCC=1C=CC(OC)=CC=1)[H])OCC1=CC=C(OC)C=C1 IPFAQMNAEFGGLO-RACKDBBVSA-N 0.000 description 1
YZCOEUDUJYZNCY-PUHABZHSSA-N (1r,4s,6s,7s)-7-[(4-methoxyphenyl)methoxy]-4-[(4-methoxyphenyl)methoxymethyl]-6-phenyl-2,5-dioxabicyclo[2.2.1]heptane Chemical compound C([C@]12CO[C@]([C@@H](O2)C=2C=CC=CC=2)([C@@H]1OCC=1C=CC(OC)=CC=1)[H])OCC1=CC=C(OC)C=C1 YZCOEUDUJYZNCY-PUHABZHSSA-N 0.000 description 1
DUUPBSRYPVHFGN-NAQJMGRXSA-N (1r,4s,6s,7s)-7-[(4-methoxyphenyl)methoxy]-4-[(4-methoxyphenyl)methoxymethyl]-6-pyren-1-yl-2,5-dioxabicyclo[2.2.1]heptane Chemical compound C([C@]12CO[C@]([C@@H](O2)C=2C3=CC=C4C=CC=C5C=CC(C3=C54)=CC=2)([C@@H]1OCC=1C=CC(OC)=CC=1)[H])OCC1=CC=C(OC)C=C1 DUUPBSRYPVHFGN-NAQJMGRXSA-N 0.000 description 1
JPNANMFQLUCEHB-DBSNRUDNSA-N (1r,4s,7s)-6-methoxy-7-[(4-methoxyphenyl)methoxy]-4-[(4-methoxyphenyl)methoxymethyl]-2,5-dioxabicyclo[2.2.1]heptane Chemical compound C([C@]12CO[C@@](C(O2)OC)([C@@H]1OCC=1C=CC(OC)=CC=1)[H])OCC1=CC=C(OC)C=C1 JPNANMFQLUCEHB-DBSNRUDNSA-N 0.000 description 1
PDWIQYODPROSQH-VPENINKCSA-N (2r,4s,5r)-5-(hydroxymethyl)oxolane-2,4-diol Chemical compound OC[C@H]1O[C@@H](O)C[C@@H]1O PDWIQYODPROSQH-VPENINKCSA-N 0.000 description 1
TWYYFYNJOJGNFP-CUXYNZQBSA-N (2s,4r,5s,6s)-2-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-2-carbamoyl-4-[[(e,4s,6s)-4,6-dimethyloct-2-enoyl]oxymethyl]-5-hydroxy-1,3-dioxane-4,5,6-tricarboxylic acid Chemical compound O1[C@H](C(O)=O)[C@](C(O)=O)(O)[C@](COC(=O)/C=C/[C@@H](C)C[C@@H](C)CC)(C(O)=O)O[C@]1(C(N)=O)CCC(=C)[C@@H](OC(C)=O)[C@H](C)CC1=CC=CC=C1 TWYYFYNJOJGNFP-CUXYNZQBSA-N 0.000 description 1
QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 1
125000003837 (C1-C20) alkyl group Chemical group 0.000 description 1
DVFAVJDEPNXAME-UHFFFAOYSA-N 1,4-dimethylanthracene-9,10-dione Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2C DVFAVJDEPNXAME-UHFFFAOYSA-N 0.000 description 1
MAUZREPGYMCMTD-UHFFFAOYSA-N 1,5,7-triazaspiro[3.5]non-8-en-6-one Chemical compound N1C(=O)NC=CC11NCC1 MAUZREPGYMCMTD-UHFFFAOYSA-N 0.000 description 1
HASUWNAFLUMMFI-UHFFFAOYSA-N 1,7-dihydropyrrolo[2,3-d]pyrimidine-2,4-dione Chemical compound O=C1NC(=O)NC2=C1C=CN2 HASUWNAFLUMMFI-UHFFFAOYSA-N 0.000 description 1
MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 1
BHKKSKOHRFHHIN-MRVPVSSYSA-N 1-[[2-[(1R)-1-aminoethyl]-4-chlorophenyl]methyl]-2-sulfanylidene-5H-pyrrolo[3,2-d]pyrimidin-4-one Chemical compound N[C@H](C)C1=C(CN2C(NC(C3=C2C=CN3)=O)=S)C=CC(=C1)Cl BHKKSKOHRFHHIN-MRVPVSSYSA-N 0.000 description 1
AWNXKZVIZARMME-UHFFFAOYSA-N 1-[[5-[2-[(2-chloropyridin-4-yl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol Chemical compound N=1C(NCC(C)(O)C)=NC=C(C=2N=C(NC=3C=C(Cl)N=CC=3)N=CC=2)C=1CC1CC1 AWNXKZVIZARMME-UHFFFAOYSA-N 0.000 description 1
SCZXFZRJDVZMJI-UHFFFAOYSA-N 1-bromo-2,4,5-trimethylbenzene Chemical compound CC1=CC(C)=C(Br)C=C1C SCZXFZRJDVZMJI-UHFFFAOYSA-N 0.000 description 1
DLKQHBOKULLWDQ-UHFFFAOYSA-N 1-bromonaphthalene Chemical compound C1=CC=C2C(Br)=CC=CC2=C1 DLKQHBOKULLWDQ-UHFFFAOYSA-N 0.000 description 1
HYGLETVERPVXOS-UHFFFAOYSA-N 1-bromopyrene Chemical compound C1=C2C(Br)=CC=C(C=C3)C2=C2C3=CC=CC2=C1 HYGLETVERPVXOS-UHFFFAOYSA-N 0.000 description 1
FDFVVBKRHGRRFY-UHFFFAOYSA-N 1-hydroxy-2,2,5,5-tetramethylpyrrolidine Chemical compound CC1(C)CCC(C)(C)N1O FDFVVBKRHGRRFY-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
238000005160 1H NMR spectroscopy Methods 0.000 description 1
YPTJKHVBDCRKNF-UHFFFAOYSA-N 2',6'-Dihydroxyacetophenone Chemical compound CC(=O)C1=C(O)C=CC=C1O YPTJKHVBDCRKNF-UHFFFAOYSA-N 0.000 description 1
YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
VUZNLSBZRVZGIK-UHFFFAOYSA-N 2,2,6,6-Tetramethyl-1-piperidinol Chemical compound CC1(C)CCCC(C)(C)N1O VUZNLSBZRVZGIK-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
QWTBDIBOOIAZEF-UHFFFAOYSA-N 3-[chloro-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile Chemical compound CC(C)N(C(C)C)P(Cl)OCCC#N QWTBDIBOOIAZEF-UHFFFAOYSA-N 0.000 description 1
NVVPMZUGELHVMH-UHFFFAOYSA-N 3-ethyl-4-[4-[4-(1-methylpyrazol-4-yl)imidazol-1-yl]-3-propan-2-ylpyrazolo[3,4-b]pyridin-1-yl]benzamide Chemical compound CCC1=CC(C(N)=O)=CC=C1N1C2=NC=CC(N3C=C(N=C3)C3=CN(C)N=C3)=C2C(C(C)C)=N1 NVVPMZUGELHVMH-UHFFFAOYSA-N 0.000 description 1
LOJNBPNACKZWAI-UHFFFAOYSA-N 3-nitro-1h-pyrrole Chemical compound [O-][N+](=O)C=1C=CNC=1 LOJNBPNACKZWAI-UHFFFAOYSA-N 0.000 description 1
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
XDCOYBQVEVSNNB-UHFFFAOYSA-N 4-[(7-naphthalen-2-yl-1-benzothiophen-2-yl)methylamino]butanoic acid Chemical compound OC(=O)CCCNCc1cc2cccc(-c3ccc4ccccc4c3)c2s1 XDCOYBQVEVSNNB-UHFFFAOYSA-N 0.000 description 1
FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 1
UJBCLAXPPIDQEE-UHFFFAOYSA-N 5-prop-1-ynyl-1h-pyrimidine-2,4-dione Chemical compound CC#CC1=CNC(=O)NC1=O UJBCLAXPPIDQEE-UHFFFAOYSA-N 0.000 description 1
SXQMWXNOYLLRBY-UHFFFAOYSA-N 6-(methylamino)purin-8-one Chemical compound CNC1=NC=NC2=NC(=O)N=C12 SXQMWXNOYLLRBY-UHFFFAOYSA-N 0.000 description 1
LOSIULRWFAEMFL-UHFFFAOYSA-N 7-deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 description 1
CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
PZASAAIJIFDWSB-CKPDSHCKSA-N 8-[(1S)-1-[8-(trifluoromethyl)-7-[4-(trifluoromethyl)cyclohexyl]oxynaphthalen-2-yl]ethyl]-8-azabicyclo[3.2.1]octane-3-carboxylic acid Chemical compound FC(F)(F)C=1C2=CC([C@@H](N3C4CCC3CC(C4)C(O)=O)C)=CC=C2C=CC=1OC1CCC(C(F)(F)F)CC1 PZASAAIJIFDWSB-CKPDSHCKSA-N 0.000 description 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
208000035657 Abasia Diseases 0.000 description 1
241001148231 Acinetobacter haemolyticus Species 0.000 description 1
102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
241000607528 Aeromonas hydrophila Species 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
VWVKUNOPTJGDOB-BDHVOXNPSA-N Anhydrous tofogliflozin Chemical compound C1=CC(CC)=CC=C1CC1=CC=C(CO[C@@]23[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C2=C1 VWVKUNOPTJGDOB-BDHVOXNPSA-N 0.000 description 1
102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
108091023037 Aptamer Proteins 0.000 description 1
241000606125 Bacteroides Species 0.000 description 1
241001135322 Bacteroides eggerthii Species 0.000 description 1
241000606123 Bacteroides thetaiotaomicron Species 0.000 description 1
241000606219 Bacteroides uniformis Species 0.000 description 1
241000606215 Bacteroides vulgatus Species 0.000 description 1
DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
206010005003 Bladder cancer Diseases 0.000 description 1
241000588779 Bordetella bronchiseptica Species 0.000 description 1
241000588780 Bordetella parapertussis Species 0.000 description 1
241000588832 Bordetella pertussis Species 0.000 description 1
241000589968 Borrelia Species 0.000 description 1
102400000967 Bradykinin Human genes 0.000 description 1
101800004538 Bradykinin Proteins 0.000 description 1
208000003174 Brain Neoplasms Diseases 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
208000026310 Breast neoplasm Diseases 0.000 description 1
241000589513 Burkholderia cepacia Species 0.000 description 1
UGGKUTUDTQIUSR-UHFFFAOYSA-N C(C)(C)N(P(=O)(NC(C)C)N)CCC#N Chemical compound C(C)(C)N(P(=O)(NC(C)C)N)CCC#N UGGKUTUDTQIUSR-UHFFFAOYSA-N 0.000 description 1
229930182476 C-glycoside Natural products 0.000 description 1
241000589877 Campylobacter coli Species 0.000 description 1
241000589874 Campylobacter fetus Species 0.000 description 1
241000589875 Campylobacter jejuni Species 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
108090000994 Catalytic RNA Proteins 0.000 description 1
102000053642 Catalytic RNA Human genes 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
201000006082 Chickenpox Diseases 0.000 description 1
241001647373 Chlamydia abortus Species 0.000 description 1
241001647372 Chlamydia pneumoniae Species 0.000 description 1
241001647378 Chlamydia psittaci Species 0.000 description 1
241000606153 Chlamydia trachomatis Species 0.000 description 1
208000002691 Choroiditis Diseases 0.000 description 1
241000588919 Citrobacter freundii Species 0.000 description 1
241000193163 Clostridioides difficile Species 0.000 description 1
108091033380 Coding strand Proteins 0.000 description 1
108020004394 Complementary RNA Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
241001517050 Corynebacterium accolens Species 0.000 description 1
241001517048 Corynebacterium afermentans Species 0.000 description 1
241000158508 Corynebacterium amycolatum Species 0.000 description 1
241000168411 Corynebacterium auris Species 0.000 description 1
241001508000 Corynebacterium bovis Species 0.000 description 1
241001233907 Corynebacterium confusum Species 0.000 description 1
241000520076 Corynebacterium coyleae Species 0.000 description 1
241000186227 Corynebacterium diphtheriae Species 0.000 description 1
241000880909 Corynebacterium durum Species 0.000 description 1
241001547340 Corynebacterium falsenii Species 0.000 description 1
241001533284 Corynebacterium glucuronolyticum Species 0.000 description 1
241000024402 Corynebacterium imitans Species 0.000 description 1
241001517041 Corynebacterium jeikeium Species 0.000 description 1
241000334646 Corynebacterium kroppenstedtii Species 0.000 description 1
241001495430 Corynebacterium kutscheri Species 0.000 description 1
241001517018 Corynebacterium macginleyi Species 0.000 description 1
241000158496 Corynebacterium matruchotii Species 0.000 description 1
241000577797 Corynebacterium mucifaciens Species 0.000 description 1
241001495433 Corynebacterium pilosum Species 0.000 description 1
241000158499 Corynebacterium propinquum Species 0.000 description 1
241000186246 Corynebacterium renale Species 0.000 description 1
241000024400 Corynebacterium riegelii Species 0.000 description 1
241000334675 Corynebacterium singulare Species 0.000 description 1
241000158523 Corynebacterium striatum Species 0.000 description 1
241000334945 Corynebacterium sundsvallense Species 0.000 description 1
241000895659 Corynebacterium thomssenii Species 0.000 description 1
241000918600 Corynebacterium ulcerans Species 0.000 description 1
241000158520 Corynebacterium urealyticum Species 0.000 description 1
241000186245 Corynebacterium xerosis Species 0.000 description 1
MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108020001019 DNA Primers Proteins 0.000 description 1
102100035186 DNA excision repair protein ERCC-1 Human genes 0.000 description 1
102100031866 DNA excision repair protein ERCC-5 Human genes 0.000 description 1
238000000018 DNA microarray Methods 0.000 description 1
102100029094 DNA repair endonuclease XPF Human genes 0.000 description 1
230000007023 DNA restriction-modification system Effects 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
108010053770 Deoxyribonucleases Proteins 0.000 description 1
102000016911 Deoxyribonucleases Human genes 0.000 description 1
YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 description 1
241000588697 Enterobacter cloacae Species 0.000 description 1
241001468179 Enterococcus avium Species 0.000 description 1
241000178336 Enterococcus cecorum Species 0.000 description 1
241000178337 Enterococcus dispar Species 0.000 description 1
241000520130 Enterococcus durans Species 0.000 description 1
241000194032 Enterococcus faecalis Species 0.000 description 1
241000194031 Enterococcus faecium Species 0.000 description 1
241000194030 Enterococcus gallinarum Species 0.000 description 1
241000194029 Enterococcus hirae Species 0.000 description 1
241001235140 Enterococcus malodoratus Species 0.000 description 1
241000520134 Enterococcus mundtii Species 0.000 description 1
241000178338 Enterococcus pseudoavium Species 0.000 description 1
241001235138 Enterococcus raffinosus Species 0.000 description 1
241000134765 Enterococcus saccharolyticus Species 0.000 description 1
241000283086 Equidae Species 0.000 description 1
208000000832 Equine Encephalomyelitis Diseases 0.000 description 1
QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
241000589602 Francisella tularensis Species 0.000 description 1
108050007570 GTP-binding protein Rad Proteins 0.000 description 1
241000207202 Gardnerella Species 0.000 description 1
206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
238000003747 Grignard reaction Methods 0.000 description 1
QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
241000606788 Haemophilus haemolyticus Species 0.000 description 1
241000606768 Haemophilus influenzae Species 0.000 description 1
241000606822 Haemophilus parahaemolyticus Species 0.000 description 1
241000606766 Haemophilus parainfluenzae Species 0.000 description 1
241000590002 Helicobacter pylori Species 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
208000007514 Herpes zoster Diseases 0.000 description 1
108091027305 Heteroduplex Proteins 0.000 description 1
101000876529 Homo sapiens DNA excision repair protein ERCC-1 Proteins 0.000 description 1
101000913035 Homo sapiens Flap endonuclease 1 Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108010029660 Intrinsically Disordered Proteins Proteins 0.000 description 1
241001454354 Kingella Species 0.000 description 1
241000589014 Kingella kingae Species 0.000 description 1
241000589012 Kingella oralis Species 0.000 description 1
241000588915 Klebsiella aerogenes Species 0.000 description 1
241000588749 Klebsiella oxytoca Species 0.000 description 1
241000588747 Klebsiella pneumoniae Species 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
206010058467 Lung neoplasm malignant Diseases 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
241001293418 Mannheimia haemolytica Species 0.000 description 1
201000005505 Measles Diseases 0.000 description 1
241001599018 Melanogaster Species 0.000 description 1
201000009906 Meningitis Diseases 0.000 description 1
239000012359 Methanesulfonyl chloride Substances 0.000 description 1
241001478301 Moraxella atlantae Species 0.000 description 1
241000588629 Moraxella lacunata Species 0.000 description 1
241000588630 Moraxella nonliquefaciens Species 0.000 description 1
241001478294 Moraxella osloensis Species 0.000 description 1
241000588772 Morganella morganii Species 0.000 description 1
208000005647 Mumps Diseases 0.000 description 1
101000878884 Mus musculus Flap endonuclease 1 Proteins 0.000 description 1
241000186367 Mycobacterium avium Species 0.000 description 1
241000186364 Mycobacterium intracellulare Species 0.000 description 1
241000186362 Mycobacterium leprae Species 0.000 description 1
241000187479 Mycobacterium tuberculosis Species 0.000 description 1
FUSGACRLAFQQRL-UHFFFAOYSA-N N-Ethyl-N-nitrosourea Chemical compound CCN(N=O)C(N)=O FUSGACRLAFQQRL-UHFFFAOYSA-N 0.000 description 1
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
229930192627 Naphthoquinone Natural products 0.000 description 1
241000588652 Neisseria gonorrhoeae Species 0.000 description 1
108020004485 Nonsense Codon Proteins 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108091005461 Nucleic proteins Proteins 0.000 description 1
229910003849 O-Si Inorganic materials 0.000 description 1
241001135232 Odoribacter splanchnicus Species 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
241000713112 Orthobunyavirus Species 0.000 description 1
206010033128 Ovarian cancer Diseases 0.000 description 1
206010061535 Ovarian neoplasm Diseases 0.000 description 1
229910003872 O—Si Inorganic materials 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
RPDUDBYMNGAHEM-UHFFFAOYSA-N PROXYL Chemical compound CC1(C)CCC(C)(C)N1[O] RPDUDBYMNGAHEM-UHFFFAOYSA-N 0.000 description 1
206010061902 Pancreatic neoplasm Diseases 0.000 description 1
241001631646 Papillomaviridae Species 0.000 description 1
241001647381 Parachlamydia acanthamoebae Species 0.000 description 1
241000606856 Pasteurella multocida Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
108010033276 Peptide Fragments Proteins 0.000 description 1
102000007079 Peptide Fragments Human genes 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
241001505332 Polyomavirus sp. Species 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
208000003971 Posterior uveitis Diseases 0.000 description 1
206010060862 Prostate cancer Diseases 0.000 description 1
208000000236 Prostatic Neoplasms Diseases 0.000 description 1
241000588770 Proteus mirabilis Species 0.000 description 1
241000588767 Proteus vulgaris Species 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
241000168225 Pseudomonas alcaligenes Species 0.000 description 1
241001646398 Pseudomonas chlororaphis Species 0.000 description 1
241000589540 Pseudomonas fluorescens Species 0.000 description 1
241000218905 Pseudomonas luteola Species 0.000 description 1
241000589776 Pseudomonas putida Species 0.000 description 1
241000589614 Pseudomonas stutzeri Species 0.000 description 1
241001148186 Psychrobacter phenylpyruvicus Species 0.000 description 1
108091030071 RNAI Proteins 0.000 description 1
206010037742 Rabies Diseases 0.000 description 1
208000004337 Salivary Gland Neoplasms Diseases 0.000 description 1
206010061934 Salivary gland cancer Diseases 0.000 description 1
241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
229910052772 Samarium Inorganic materials 0.000 description 1
101100411621 Schizosaccharomyces pombe (strain 972 / ATCC 24843) rad16 gene Proteins 0.000 description 1
241000239226 Scorpiones Species 0.000 description 1
239000012506 Sephacryl® Substances 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
241000607715 Serratia marcescens Species 0.000 description 1
241000607760 Shigella sonnei Species 0.000 description 1
229910004298 SiO 2 Inorganic materials 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
241001647368 Simkania negevensis Species 0.000 description 1
102000039471 Small Nuclear RNA Human genes 0.000 description 1
108020004688 Small Nuclear RNA Proteins 0.000 description 1
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
206010041896 St. Louis Encephalitis Diseases 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
241000191963 Staphylococcus epidermidis Species 0.000 description 1
241000192087 Staphylococcus hominis Species 0.000 description 1
241000191982 Staphylococcus hyicus Species 0.000 description 1
241000191980 Staphylococcus intermedius Species 0.000 description 1
241001147691 Staphylococcus saprophyticus Species 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
208000005718 Stomach Neoplasms Diseases 0.000 description 1
241000193985 Streptococcus agalactiae Species 0.000 description 1
241000193998 Streptococcus pneumoniae Species 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
241001235136 Tetragenococcus solitarius Species 0.000 description 1
108091023040 Transcription factor Proteins 0.000 description 1
102000040945 Transcription factor Human genes 0.000 description 1
239000007984 Tris EDTA buffer Substances 0.000 description 1
108010020713 Tth polymerase Proteins 0.000 description 1
208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
206010046980 Varicella Diseases 0.000 description 1
241000607626 Vibrio cholerae Species 0.000 description 1
FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
229930003316 Vitamin D Natural products 0.000 description 1
QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
241000269370 Xenopus <genus> Species 0.000 description 1
241000607447 Yersinia enterocolitica Species 0.000 description 1
241000607481 Yersinia intermedia Species 0.000 description 1
241000607479 Yersinia pestis Species 0.000 description 1
MQSDZBXLJRAKPY-GLDWBXLXSA-N [(1r,4r,7s)-6-methoxy-7-[(4-methoxyphenyl)methoxy]-2,5-dioxabicyclo[2.2.1]heptan-4-yl]methyl acetate Chemical compound O([C@@H]1[C@]2(COC(C)=O)CO[C@]1(C(O2)OC)[H])CC1=CC=C(OC)C=C1 MQSDZBXLJRAKPY-GLDWBXLXSA-N 0.000 description 1
HRNUOXVPNRAGQB-VPHRMDQISA-N [(1r,4s,7s)-6-methoxy-7-[(4-methoxyphenyl)methoxy]-2,5-dioxabicyclo[2.2.1]heptan-4-yl]methanol Chemical compound O([C@@H]1[C@]2(CO)CO[C@]1(C(O2)OC)[H])CC1=CC=C(OC)C=C1 HRNUOXVPNRAGQB-VPHRMDQISA-N 0.000 description 1
XXTGMWLOVIXQQT-YSPPHNQVSA-N [(3s,4r)-4-hydroxy-5-methoxy-3-[(4-methoxyphenyl)methoxy]-2-(methylsulfonyloxymethyl)oxolan-2-yl]methyl methanesulfonate Chemical compound O[C@H]1C(OC)OC(COS(C)(=O)=O)(COS(C)(=O)=O)[C@H]1OCC1=CC=C(OC)C=C1 XXTGMWLOVIXQQT-YSPPHNQVSA-N 0.000 description 1
DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
241000606834 [Haemophilus] ducreyi Species 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
229960000583 acetic acid Drugs 0.000 description 1
125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
238000001042 affinity chromatography Methods 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
125000000304 alkynyl group Chemical group 0.000 description 1
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
238000007844 allele-specific PCR Methods 0.000 description 1
HMFHBZSHGGEWLO-AIHAYLRMSA-N alpha-D-ribose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-AIHAYLRMSA-N 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
238000004873 anchoring Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000013528 artificial neural network Methods 0.000 description 1
CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
230000008901 benefit Effects 0.000 description 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
239000012965 benzophenone Substances 0.000 description 1
SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
125000001743 benzylic group Chemical group 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
HMFHBZSHGGEWLO-TXICZTDVSA-N beta-D-ribose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-TXICZTDVSA-N 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
108010005774 beta-Galactosidase Proteins 0.000 description 1
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
229940017687 beta-d-ribose Drugs 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
238000006664 bond formation reaction Methods 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical class OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
150000001649 bromium compounds Chemical class 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
125000001589 carboacyl group Chemical group 0.000 description 1
239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
150000003857 carboxamides Chemical class 0.000 description 1
150000001731 carboxylic acid azides Chemical class 0.000 description 1
150000001733 carboxylic acid esters Chemical class 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000013522 chelant Substances 0.000 description 1
229940038705 chlamydia trachomatis Drugs 0.000 description 1
150000001805 chlorine compounds Chemical class 0.000 description 1
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
125000002676 chrysenyl group Chemical group C1(=CC=CC=2C3=CC=C4C=CC=CC4=C3C=CC12)* 0.000 description 1
DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
229960004316 cisplatin Drugs 0.000 description 1
108010041758 cleavase Proteins 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
239000003184 complementary RNA Substances 0.000 description 1
239000002131 composite material Substances 0.000 description 1
229940125773 compound 10 Drugs 0.000 description 1
229940125782 compound 2 Drugs 0.000 description 1
229940125898 compound 5 Drugs 0.000 description 1
238000011443 conventional therapy Methods 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
238000009223 counseling Methods 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
231100000599 cytotoxic agent Toxicity 0.000 description 1
239000002619 cytotoxin Substances 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000006196 deacetylation Effects 0.000 description 1
238000003381 deacetylation reaction Methods 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
230000001687 destabilization Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 1
150000008049 diazo compounds Chemical class 0.000 description 1
FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
PGUYAANYCROBRT-UHFFFAOYSA-N dihydroxy-selanyl-selanylidene-lambda5-phosphane Chemical compound OP(O)([SeH])=[Se] PGUYAANYCROBRT-UHFFFAOYSA-N 0.000 description 1
239000000539 dimer Substances 0.000 description 1
235000010300 dimethyl dicarbonate Nutrition 0.000 description 1
VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
150000002009 diols Chemical class 0.000 description 1
NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
125000002228 disulfide group Chemical group 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
239000000975 dye Substances 0.000 description 1
230000005670 electromagnetic radiation Effects 0.000 description 1
238000000804 electron spin resonance spectroscopy Methods 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
239000003480 eluent Substances 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000007463 endoscopic sphincterotomy Methods 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
238000001400 expression cloning Methods 0.000 description 1
150000004665 fatty acids Chemical group 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000003818 flash chromatography Methods 0.000 description 1
ODKNJVUHOIMIIZ-RRKCRQDMSA-N floxuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ODKNJVUHOIMIIZ-RRKCRQDMSA-N 0.000 description 1
239000003269 fluorescent indicator Substances 0.000 description 1
229910052731 fluorine Inorganic materials 0.000 description 1
239000011737 fluorine Substances 0.000 description 1
150000002222 fluorine compounds Chemical class 0.000 description 1
229960002949 fluorouracil Drugs 0.000 description 1
229960000304 folic acid Drugs 0.000 description 1
235000019152 folic acid Nutrition 0.000 description 1
239000011724 folic acid Substances 0.000 description 1
231100000221 frame shift mutation induction Toxicity 0.000 description 1
230000037433 frameshift Effects 0.000 description 1
229940118764 francisella tularensis Drugs 0.000 description 1
125000002541 furyl group Chemical group 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
206010017758 gastric cancer Diseases 0.000 description 1
239000000499 gel Substances 0.000 description 1
230000009368 gene silencing by RNA Effects 0.000 description 1
239000012362 glacial acetic acid Substances 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
229940029575 guanosine Drugs 0.000 description 1
229940047650 haemophilus influenzae Drugs 0.000 description 1
229940037467 helicobacter pylori Drugs 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
125000005553 heteroaryloxy group Chemical group 0.000 description 1
125000005226 heteroaryloxycarbonyl group Chemical group 0.000 description 1
150000002391 heterocyclic compounds Chemical class 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
150000002443 hydroxylamines Chemical class 0.000 description 1
150000002460 imidazoles Chemical class 0.000 description 1
125000002883 imidazolyl group Chemical group 0.000 description 1
125000001841 imino group Chemical group [H]N=* 0.000 description 1
NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
230000003100 immobilizing effect Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
150000002475 indoles Chemical class 0.000 description 1
125000001041 indolyl group Chemical group 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000001361 intraarterial administration Methods 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000002955 isolation Methods 0.000 description 1
125000000842 isoxazolyl group Chemical group 0.000 description 1
ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000004020 luminiscence type Methods 0.000 description 1
201000005202 lung cancer Diseases 0.000 description 1
208000020816 lung neoplasm Diseases 0.000 description 1
238000010841 mRNA extraction Methods 0.000 description 1
230000005291 magnetic effect Effects 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
238000009115 maintenance therapy Methods 0.000 description 1
208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
239000000463 material Substances 0.000 description 1
238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
201000001441 melanoma Diseases 0.000 description 1
239000012528 membrane Substances 0.000 description 1
125000005905 mesyloxy group Chemical group 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000006140 methanolysis reaction Methods 0.000 description 1
GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
244000000010 microbial pathogen Species 0.000 description 1
150000004712 monophosphates Chemical class 0.000 description 1
229940076266 morganella morganii Drugs 0.000 description 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
208000010805 mumps infectious disease Diseases 0.000 description 1
QAPTWHXHEYAIKG-RCOXNQKVSA-N n-[(1r,2s,5r)-5-(tert-butylamino)-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 QAPTWHXHEYAIKG-RCOXNQKVSA-N 0.000 description 1
150000002791 naphthoquinones Chemical class 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
150000002829 nitrogen Chemical class 0.000 description 1
239000012299 nitrogen atmosphere Substances 0.000 description 1
230000037434 nonsense mutation Effects 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
238000012587 nuclear overhauser effect experiment Methods 0.000 description 1
238000003499 nucleic acid array Methods 0.000 description 1
238000007899 nucleic acid hybridization Methods 0.000 description 1
230000000269 nucleophilic effect Effects 0.000 description 1
SBOJXQVPLKSXOG-UHFFFAOYSA-N o-amino-hydroxylamine Chemical compound NON SBOJXQVPLKSXOG-UHFFFAOYSA-N 0.000 description 1
238000002515 oligonucleotide synthesis Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
150000002916 oxazoles Chemical class 0.000 description 1
125000002971 oxazolyl group Chemical group 0.000 description 1
125000004043 oxo group Chemical group O=* 0.000 description 1
201000002528 pancreatic cancer Diseases 0.000 description 1
208000008443 pancreatic carcinoma Diseases 0.000 description 1
238000004091 panning Methods 0.000 description 1
230000005298 paramagnetic effect Effects 0.000 description 1
229940051027 pasteurella multocida Drugs 0.000 description 1
230000035515 penetration Effects 0.000 description 1
150000002972 pentoses Chemical class 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
125000001792 phenanthrenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3C=CC12)* 0.000 description 1
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
ANRQGKOBLBYXFM-UHFFFAOYSA-M phenylmagnesium bromide Chemical compound Br[Mg]C1=CC=CC=C1 ANRQGKOBLBYXFM-UHFFFAOYSA-M 0.000 description 1
PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical compound NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000003566 phosphorylation assay Methods 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000013612 plasmid Substances 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
125000003367 polycyclic group Chemical group 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920000232 polyglycine polymer Polymers 0.000 description 1
102000054765 polymorphisms of proteins Human genes 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000037452 priming Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
235000019833 protease Nutrition 0.000 description 1
108020001580 protein domains Proteins 0.000 description 1
230000004850 protein–protein interaction Effects 0.000 description 1
229940007042 proteus vulgaris Drugs 0.000 description 1
125000003373 pyrazinyl group Chemical group 0.000 description 1
125000004076 pyridyl group Chemical group 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
230000001698 pyrogenic effect Effects 0.000 description 1
125000000168 pyrrolyl group Chemical group 0.000 description 1
238000010791 quenching Methods 0.000 description 1
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000001525 receptor binding assay Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
108091092562 ribozyme Proteins 0.000 description 1
238000006798 ring closing metathesis reaction Methods 0.000 description 1
KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
JRPHGDYSKGJTKZ-UHFFFAOYSA-N selenophosphoric acid Chemical compound OP(O)([SeH])=O JRPHGDYSKGJTKZ-UHFFFAOYSA-N 0.000 description 1
238000002864 sequence alignment Methods 0.000 description 1
230000037432 silent mutation Effects 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
239000012312 sodium hydride Substances 0.000 description 1
239000002689 soil Substances 0.000 description 1
230000009870 specific binding Effects 0.000 description 1
125000003003 spiro group Chemical group 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
238000012409 standard PCR amplification Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
239000003270 steroid hormone Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
201000011549 stomach cancer Diseases 0.000 description 1
229940031000 streptococcus pneumoniae Drugs 0.000 description 1
238000012916 structural analysis Methods 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
229940042055 systemic antimycotics triazole derivative Drugs 0.000 description 1
125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
125000000335 thiazolyl group Chemical group 0.000 description 1
125000001544 thienyl group Chemical group 0.000 description 1
150000003568 thioethers Chemical group 0.000 description 1
229930192474 thiophene Natural products 0.000 description 1
RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
125000000464 thioxo group Chemical group S=* 0.000 description 1
229940104230 thymidine Drugs 0.000 description 1
210000001541 thymus gland Anatomy 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000014616 translation Effects 0.000 description 1
TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
239000001226 triphosphate Substances 0.000 description 1
235000011178 triphosphate Nutrition 0.000 description 1
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
238000011144 upstream manufacturing Methods 0.000 description 1
201000005112 urinary bladder cancer Diseases 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
235000019155 vitamin A Nutrition 0.000 description 1
239000011719 vitamin A Substances 0.000 description 1
235000019166 vitamin D Nutrition 0.000 description 1
239000011710 vitamin D Substances 0.000 description 1
150000003710 vitamin D derivatives Chemical class 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
229940045997 vitamin a Drugs 0.000 description 1
229940046008 vitamin d Drugs 0.000 description 1
239000002699 waste material Substances 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
238000001262 western blot Methods 0.000 description 1
229940075420 xanthine Drugs 0.000 description 1
229940098232 yersinia enterocolitica Drugs 0.000 description 1